WOOJUNG BIO, Inc. (KOSDAQ:215380)

WOOJUNG BIO Statistics

Total Valuation

WOOJUNG BIO has a market cap or net worth of KRW 52.68 billion. The enterprise value is 99.08 billion.

Market Cap	52.68B
Enterprise Value	99.08B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

WOOJUNG BIO has 16.83 million shares outstanding. The number of shares has increased by 10.90% in one year.

Current Share Class	16.83M
Shares Outstanding	16.83M
Shares Change (YoY)	+10.90%
Shares Change (QoQ)	-10.96%
Owned by Insiders (%)	33.61%
Owned by Institutions (%)	3.65%
Float	4.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.40
PB Ratio	2.25
P/TBV Ratio	2.34
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.86
EV / Sales	2.64
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-112.02

Financial Position

The company has a current ratio of 0.57, with a Debt / Equity ratio of 2.16.

Current Ratio	0.57
Quick Ratio	0.26
Debt / Equity	2.16
Debt / EBITDA	432.05
Debt / FCF	-57.12
Interest Coverage	-1.26

Financial Efficiency

Return on equity (ROE) is -21.03% and return on invested capital (ROIC) is -5.09%.

Return on Equity (ROE)	-21.03%
Return on Assets (ROA)	-2.52%
Return on Invested Capital (ROIC)	-5.09%
Return on Capital Employed (ROCE)	-6.44%
Weighted Average Cost of Capital (WACC)	5.95%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.41
Inventory Turnover	4.26

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +104.74% in the last 52 weeks. The beta is 0.56, so WOOJUNG BIO's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+104.74%
50-Day Moving Average	2,806.40
200-Day Moving Average	2,125.85
Relative Strength Index (RSI)	55.65
Average Volume (20 Days)	789,293

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WOOJUNG BIO had revenue of KRW 37.59 billion and -5.55 billion in losses. Loss per share was -333.00.

Revenue	37.59B
Gross Profit	10.00B
Operating Income	-3.65B
Pretax Income	-5.55B
Net Income	-5.55B
EBITDA	116.94M
EBIT	-3.65B
Loss Per Share	-333.00

Balance Sheet

The company has 4.12 billion in cash and 50.52 billion in debt, with a net cash position of -46.40 billion or -2,757.26 per share.

Cash & Cash Equivalents	4.12B
Total Debt	50.52B
Net Cash	-46.40B
Net Cash Per Share	-2,757.26
Equity (Book Value)	23.38B
Book Value Per Share	1,407.11
Working Capital	-12.93B

Cash Flow

In the last 12 months, operating cash flow was -630.50 million and capital expenditures -253.96 million, giving a free cash flow of -884.46 million.

Operating Cash Flow	-630.50M
Capital Expenditures	-253.96M
Depreciation & Amortization	3.77B
Net Borrowing	-1.63B
Free Cash Flow	-884.46M
FCF Per Share	-52.55

Margins

Gross margin is 26.61%, with operating and profit margins of -9.72% and -14.76%.

Gross Margin	26.61%
Operating Margin	-9.72%
Pretax Margin	-14.76%
Profit Margin	-14.76%
EBITDA Margin	0.31%
EBIT Margin	-9.72%
FCF Margin	n/a

Dividends & Yields

WOOJUNG BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.90%
Shareholder Yield	-10.90%
Earnings Yield	-10.53%
FCF Yield	-1.68%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 30, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jul 30, 2019
Split Type	Forward
Split Ratio	2

Scores

WOOJUNG BIO has an Altman Z-Score of -0.11 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.11
Piotroski F-Score	1